PlainRecalls
FDA Drug Moderate Class II Ongoing

Ciprofloxacin Ophthalmic Solution USP, 0.3% as base, Sterile, package in 5 mL bottles, Rx Only, Distributed by: Leading Pharma LLC, Fairfield, NJ. Manufactured by: FDC Limited, Maharashtra, India, NDC 69315-308-05

Reported: January 15, 2025 Initiated: December 16, 2024 #D-0182-2025

Product Description

Ciprofloxacin Ophthalmic Solution USP, 0.3% as base, Sterile, package in 5 mL bottles, Rx Only, Distributed by: Leading Pharma LLC, Fairfield, NJ. Manufactured by: FDC Limited, Maharashtra, India, NDC 69315-308-05

Reason for Recall

Defective container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle

Details

Recalling Firm
FDC Limited
Units Affected
136,181 bottles
Distribution
Nationwide
Location
Aurangabad, Maharashtra State

Frequently Asked Questions

What product was recalled?
Ciprofloxacin Ophthalmic Solution USP, 0.3% as base, Sterile, package in 5 mL bottles, Rx Only, Distributed by: Leading Pharma LLC, Fairfield, NJ. Manufactured by: FDC Limited, Maharashtra, India, NDC 69315-308-05. Recalled by FDC Limited. Units affected: 136,181 bottles.
Why was this product recalled?
Defective container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle
Which agency issued this recall?
This recall was issued by the FDA Drug on January 15, 2025. Severity: Moderate. Recall number: D-0182-2025.